Opus Genetics, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Opus Genetics, Inc. reported Cash And Cash Equivalents At Carrying Value of $45.09 million for the year ending 2025.

  • Opus Genetics, Inc. showed an increase of +48.7% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from Opus Genetics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
  • XBRL data for this metric is available from 2008 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Quarterly values from 10-Q filings: Q1 2001: $0.00 | Q2 2010: $17.81 million | Q3 2010: $15.83 million | Q1 2011: $20.51 million | Q2 2011: $16.13 million | Q3 2011: $13.22 million | Q1 2012: $8.10 million | Q2 2012: $8.48 million | Q3 2012: $7.38 million | Q1 2013: $12.07 million | Q2 2013: $9.98 million | Q3 2013: $14.87 million | Q1 2014: $40.07 million | Q2 2014: $38.10 million | Q3 2014: $14.97 million | Q1 2015: $10.73 million | Q2 2015: $9.97 million | Q3 2015: $12.45 million | Q1 2016: $10.46 million | Q2 2016: $7.88 million | Q3 2016: $8.39 million | Q1 2017: $10.49 million | Q2 2017: $8.79 million | Q3 2017: $8.23 million | Q1 2018: $6.30 million | Q2 2018: $5.09 million | Q3 2018: $4.59 million | Q3 2022: $13.86 million | Q1 2023: $38.99 million | Q2 2023: $39.98 million | Q3 2023: $42.35 million | Q1 2024: $47.16 million | Q2 2024: $41.41 million | Q3 2024: $36.63 million | Q1 2025: $41.79 million | Q2 2025: $32.43 million | Q3 2025: $30.82 million.
  • Over the full 16 years of available data (2008 to 2025), Opus Genetics, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 12,115.5%.
  • Historical annual values: Fiscal year 2025: $45.09 million | Fiscal year 2024: $30.32 million | Fiscal year 2023: $50.50 million | Fiscal year 2022: $42.63 million | Fiscal year 2021: $24.53 million | Fiscal year 2018: $8.74 million | Fiscal year 2017: $8.90 million | Fiscal year 2016: $11.58 million | Fiscal year 2015: $10.20 million | Fiscal year 2014: $9.83 million | Fiscal year 2013: $18.69 million | Fiscal year 2012: $13.49 million | Fiscal year 2011: $9.86 million | Fiscal year 2010: $12.34 million | Fiscal year 2009: $7.30 million | Fiscal year 2008: $369.1 thousand.
  • Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: